Pentwater Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Pentwater Capital Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-564,714	Closed	-$42.5M	–	205
2022 Q2	$42.5M	Buy	+564,714	New	+$25.1M	0.5%	41
2019 Q4	–	Sell	-15,000	Closed	-$564K	–	189
2019 Q3	$564K	Buy	+15,000	New	+$653K	0.01%	130

Pentwater Capital Management's TPTX Position: Q3 2022 in Review

Pentwater Capital Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 564,714 shares — an estimated $42.5M sold.

Pentwater Capital Management first reported a position in TPTX in Q3 2019 and held it in 2 quarters. The position peaked at $42.5M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Pentwater Capital Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Pentwater Capital Management sold 564,714 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $42.5M.
Pentwater Capital Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
Pentwater Capital Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $42.5M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Pentwater Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.